Last year, over 15 million people died from heart disease. According to the WHO, heart disease is the leading cause of death in the world, but the way we train our physicians to diagnose heart conditions has not changed since the technology was developed in the 1990s. Today, cardiologists and surgeons train in three ways that are problematic—either on a living patient, which is dangerous, or on an animal or cadaver, which is not an accurate representation of what they encounter in the field.
To help physicians enhance their practical skills, we have developed simulators that give the most realistic impression of a real patient examination or surgery. We are the world’s first company which uses heart models converted from computed tomography (CT) scans from patients with various pathologies, instead of synthetic heart models based on computer graphics as is the industry standard. The first product, successfully launched to market, is a transesophageal echocardiography (TEE) simulator, already tested and verified by more than 800 cardiologists. The device allows doctors to more effectively train in the diagnosis and detection of a number of cardiac diseases.
We have gained strategic partnerships with Columbia University and the American Cardiovascular Research Foundation (CRF). Moreover, in the third quarter of 2017, we will work with U.S.-based company Harpoon Medical to introduce a new simulator of micro-invasive mitral valve intervention, which will help to revolutionize the approach to heart surgery.